# Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

> **NCT01957709** · EARLY_PHASE1 · TERMINATED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Myxoid Liposarcoma
- Round Cell Liposarcoma
- Synovial Sarcoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **BIOLOGICAL:** Recombinant Interferon Gamma

## Key facts

- **NCT ID:** NCT01957709
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09-25
- **Primary completion:** 2018-06-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Enough samples were collected for data analysis.
- **Last updated:** 2019-07-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01957709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01957709, "Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01957709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*